No abstract available
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Biomarkers
-
Breast Neoplasms / complications*
-
Breast Neoplasms / drug therapy
-
Female
-
Humans
-
Magnetic Resonance Imaging / methods
-
Middle Aged
-
Piperazines / administration & dosage
-
Piperazines / adverse effects*
-
Piperazines / therapeutic use
-
Posterior Leukoencephalopathy Syndrome / diagnosis*
-
Posterior Leukoencephalopathy Syndrome / etiology*
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / adverse effects*
-
Protein Kinase Inhibitors / therapeutic use
-
Pyridines / administration & dosage
-
Pyridines / adverse effects*
-
Pyridines / therapeutic use
Substances
-
Antineoplastic Agents
-
Biomarkers
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyridines
-
palbociclib